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The present study describes the development of a novel
analytical approach that can reduce by 50-fold the con-
sumption of organic solvents in the charge transfer (CT)-
-based spectrophotometric analysis. The proposed ap-
proach employed 96-microwell assay plates for carrying
out the reaction. The CT reaction between the electron-
-donating analyte and electron-accepting reagent was
performed in microwells (200-mL of organic solvent) and
the color signals were measured with a microwell-plate
reader. Optimum conditions for the proposed approach
were established for two antihypertensive drugs, namely
ramipril (RML) and lisinopril (LSL) as model compounds
for the electron-donating analytes, and 2,3-dichloro-5,6-
-dicyano-1,4-benzoquinone (DDQ) as a p-electron accep-
tor. Under the optimum conditions, Beer’s law was obeyed
in the concentration range of 6–100 and 6–60 mg mL–1 for
RML and LSL, respectively. The limits of detection were
0.97 and 1.10 mg mL–1 for RML and LSL, respectively.
The precision of the methods was satisfactory; the values
of relative standard deviations did not exceed 1.1 %. The
proposed approach was successfully applied to the analy-
sis of pharmaceutical dosage forms with good accuracy
and precision. The results were comparable with those of
the reported methods. The approach described herein is
of great practical value in pharmaceutical analysis becau-
se it reduces the exposure of analysts to the toxic effects
of organic solvents, lowers the analysis cost by 50-fold,
and it has a high throughput property. Although the ap-
proach was validated for RML and LSL, the same meth-
odology could be used for any electron-donating analyte
for which a CT-reaction can be performed.
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Spectrophotometry is the most widely used technique in pharmaceutical analysis
because of its inherent simplicity and wide availability in quality control laboratories (1).
Molecular interactions between electron-donating pharmaceutical compounds and elec-
tron acceptors are generally associated with the formation of intensely colored charge
transfer (CT) complexes, which absorb radiation in the visible region. The rapid forma-
tion of these complexes leads to their widespread utility in the development of simple
and convenient spectrophotometric methods for many pharmaceutical compounds (2–4).
However, all the CT-based spectrophotometric methods described so far suffer from the
consumption of large volumes of organic solvents. This leads to high analysis costs, and
more importantly, exposure of analysts to toxic solvents.
Many studies support the positive association between the exposure to laboratory
work with organic solvents and occurrence of dose-related neurotoxic symptoms (5), in-
creased risk of some reproductive outcomes (especially preterm and posterm births)
among women performing certain laboratory tasks (6), increased risk of spontaneous
abortion among pregnant women (7, 8), and increased risk of lymphohaematopoietic
cancer (leukemia and lymphomas) in men and women alike (9). Reduction of human ex-
posure to organic solvents is one of the main objectives of hygienists, public authorities,
World Health Organization, U.S. Environment Protection Agency, and U.S. Occupational
Safety and Health Administration. For these reasons, investigating new alternative me-
thodological approaches to reduce the consumption of organic solvents in charge-trans-
fer-based spectrophotometric analysis of the therapeutically important compounds is very
important.
The present study describes the development of a novel approach that can reduce
by 50-fold the consumption of organic solvents in the CT-based spectrophotometric ana-
lysis. In this approach, the reaction was carried out in 96-microwell plates (0.2 mL vol-
ume) instead of the conventional volumetric flasks (10 mL volume). Color signals were
measured with a microwell-plate reader.
The approach was developed, validated, and applied to the analysis of two anti-
hypertensive drugs: ramipril and lisinopril (Fig. 1), inhibitors of angiotensin-converting
enzyme, in their pharmaceutical dosage forms.
A literature survey of CT reactions of electron-donating compounds with polyha-
lo-/polycyanoquinones electron acceptors has revealed that DDQ is one of the most re-
active reagents, since its reaction with electron-donating analytes proceeds instantane-
ously (2) and yields more sensitive assays compared to other polyhaloquinones (10). For
these reasons, DDQ was selected as electron acceptor in the development of the approach
described herein.
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Fig. 1. Chemical structures of the investigated antihypertensive drugs.
The electron-donating capabilities of RML (11) and LSL (12) have been demonstra-
ted in previous reports. Since the aim of this study was to develop a new approach for
reduction of the consumption of organic solvents in the CT-based spectrophotometric
analysis of pharmaceutical compounds, RML and LSL were considered as model com-
pounds.
EXPERIMENTAL
Equipment
Absorbance microwell-plate reader (ELx808IU, BioTek Instruments Inc., USA) was
used for all measurements in 96-microwell plates. Microwell plates were obtained from
Corning/Costar Inc. (USA). Finnpipette adjustable 8 channel-pipette was purchased
from Sigma Chemical Co., USA.
Chemicals and dosage forms
Ramipril (Hoechst Orient, Cairo, Egypt) and lisinopril (Zeneca Ltd., UK) were ob-
tained and used as working standards. DDQ solution (Merck, Germany) was prepared
fresh in methanol daily. Tritace® tablets (Hoechst Orient, Egypt) are labeled to contain
2.5 mg RML per tablet. Zestril® tablets (Zeneca Ltd., UK) are labeled to contain 20 mg
LSL and 12.5 mg hydrochlorothiazide (HCT) per tablet.
Preparation of standards and sample solutions
Stock standard solutions. – Into a 5-mL calibrated flask, 10 mg of each RML and LSL
was accurately weighed, dissolved in 2 mL methanol, and made up to the volume with
the same solvent. These stock solutions were diluted with methanol to obtain suitable
concentrations in the linear range for each particular drug.
Sample solutions. – Twenty tablets of each formulation were weighed and finely
powdered. A quantity of the powder equivalent to 20 mg was transferred into a 10-mL
calibrated flask, dissolved in 2 mL methanol, swirled and sonicated for 5 min, made up
to the volume with methanol, shaken well for 15 min, and filtered. The first portion of
the filtrate was rejected, and a measured volume of the filtrate was diluted quantitati-
vely with methanol to yield suitable concentrations in the linear range of each particular
drug.
General analytical procedure
One hundred microliters of the standard or sample solution of each drug (12–200
and 12–120 mg mL-1 for RML and LSL, respectively) was transferred into wells of mi-
crowell-plates. One hundred microliters of DDQ solution (0.5 and 2 %, m/V, for RML
and LSL, respectively) was added, and the reaction was allowed to proceed at room tem-
perature (25 ± 5 C) for 15 min. Absorbances of the resulting solutions were measured at
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460 nm by the microwell-plate reader. Blank wells were treated similarly, except for 100
mL of methanol that was used instead of a sample, and the absorbances of blank wells
were abstracted from those of other wells.
Validation
The following validation parameters were assessed and evaluated according to the
pharmacopoeial guidelines (13).
Linearity and sensitivity. – Employing the above mentioned general analytical proce-
dures, the calibration curves for the analysis of both RML and LSL by the proposed ana-
lytical approach were constructed by plotting the absorbances as a function of the corre-
sponding concentrations. The regression equations for the results were derived using
the least-squares method. The limits of detection (LOD) and limits of quantitation (LOQ)
were determined using the formula: LOD or LOQ = kSDa/b, where k = 3.3 for LOD and
10 for LOQ, SDa is the standard deviation of the intercept, and b is the slope.
Accuracy and precision. – Accuracy of the proposed methodology was assessed by
analytical recovery studies. Recovery was determined by the standard addition method.
Known amounts of each of RML and LSL were added to predetermined drug-containing
dosage forms, and then determined by the recommended procedure of the proposed me-
thodology. The mean analytical recovery was calculated as the ratio of the concentra-
tions measured to the concentrations taken for analysis, expressed as percentages.
Precision was determined on samples of drug solutions at three concentration levels
for each drug by analyzing 5 replicates of each sample as a batch in a single assay run.
RESULTS AND DISCUSSION
Reaction and spectral characteristics
The interaction of each of RML and LSL with DDQ was allowed to proceed at room
temperature, and the absorption spectra of the produced chromogens were recorded. All
drugs gave red colored chromogens showing absorption maxima at 460, 545, and 593
nm. These bands were attributed to the formation of the radical anion DDQ– (14), which
was probably formed by the dissociation of an original donor-acceptor (D-A) complex:
Further support to this assignment was provided by the absorption maxima with
those of the DDQ radical anion produced by the iodide reduction method (15). Dissocia-
tion of the (D-A) complex was promoted by the high ionizing power of the polar solvent
and the resulting peaks in the absorption spectra of drug-acceptor reaction mixtures
were similar to the maxima of radical anions of the acceptors obtained by the iodide re-
duction method (15).
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Optimization of experimental conditions
Optimization of the experimental conditions affecting the reaction in the 96-well
format was investigated by altering each reaction variable in turn while keeping the oth-
ers constant. In all cases, measurements were carried out at 460 nm, since this maximum
gave the highest absorptivity and ultimately the highest analytical sensitivity. The re-
sults of variations in DDQ concentrations indicated that 100 mL of 0.5 and 2 % (m/V)
were the optimum DDQ concentrations for RML and LSL, respectively, as these concen-
trations gave the highest absorbance. Previous studies (4) have demonstrated that the
interaction of electron-donors with DDQ in polar solvents (e.g., acetonitrile and metha-
nol) produces charge-transfer complexes with molar absorptivity values higher than
those produced in non-polar solvents (e.g., chloroform). Methanol was selected for sub-
sequent experiments because it offered high sensitivity. The optimum reaction time was
determined by monitoring color development in the microwells at room temperature (25
 5 C). Complete color development was attained after 12 and 10 min for RML and LSL,
respectively. The developed colors of the two drugs remained stable at room tempera-
ture for at least another 30 min. Based on these facts, and to establish convenient general
methodology, reactions in subsequent experiments were allowed to proceed for 15 min
before measuring the color signals by the plate reader. A summary of the optimum con-
ditions is given in Table I.
Validation
Linearity and sensitivity. – In all cases, Beer’s law plots (n = 5) were linear with corre-
lation coefficients in the general concentration ranges (6–100 and 6–60 mg mL1 for RML
and LSL, respectively) of 0.9998 and 0.9997 for RML and LSL, respectively (Table II). The
LOD values were 0.97 and 1.10 mg mL1 for RML and LSL, respectively. The LOQ values
were 2.95 and 3.32 mg mL1 for RML and LSL, respectively (Table II).
Accuracy and precision. – The mean analytical recovery for the proposed methodo-
logy was 100.8  0.8 and 98.8  0.8 % for RML and LSL, respectively (Table III) indicating
the accuracy of the proposed methodology.
Relative standard deviations (RSD) did not exceed 1.1 and 1.59 % for intra- and
inter-batch, respectively (Table IV), proving the high precision of the methodology for
the routine application in quality control laboratories. This high level of precision was
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Table I. Optimum conditions for the CT reaction of DDQ with ramipril and lisinopril
Conditions RML LSL
DDQ (%, m/V) 0.5 2
Solvent Methanol Methanol
Reaction time (min) 12 10
Temperature (C) 25 ± 5 25 ± 5
Measuring wavelength (nm)a 460 460
a Wavelength was determined in this study.
attributed to the accuracy of the volumes that were concomitantly dispensed into the
microwells with multi-channel pipettes (200 mL).
Selectivity. – The advantage of the proposed method is that the measurements are
performed in the visible region, away from the UV-absorbing interfering substances that
might be co-extracted from drugs-containing dosage forms. Interference from the con-
genital hydrochlorothiazide (HCT) that is co-formulated with LSL in some of its dosage
forms (Zestril® tablets) was studied in a ratio normally present in the dosage form
(LSL:HCT = 1.6). No interference from HCT with the proposed method for LSL was
found. This selectivity of the CT reaction for RML and LSL was attributed to their basic
character, which allows the CT, rather than HCT, which does not have sufficient basicity,
to achieve CT reaction (pKa = 7.9) (16). Further, no interference with the proposed me-
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Table III. Recovery of the proposed approach for determination of RML and LSL
Drug
Concentration (mg mL–1)
Recovery (%)a
Pre-analyzed Added
RML 50 40 100.8 ± 0.8
LSL 20 20 98.8 ± 0.8
a Mean ± SD (n = 3).
Table IV. Precision of the proposed approach of analysis of RML and LSL
Drug
Concentration level of
model solution (mg mL–1)
RSD (%)a
Intra-batch Inter-batch
RML 10 1.0 1.3
50 0.8 1.0
100 0.6 1.6
LSL 6 0.9 1.5
30 0.8 1.3
60 1.1 1.4
a n = 5
Table II. Quantitative analytical parameters of the proposed analytical approach for determination of
ramipril and lisinopril
Drug
Conc. range
(mg mL1)
Calibration line Correlation
coefficient (R)
LODa
(mg mL1)
LOQa
(mg mL1)Intercept ± SDa Slope ± SDb
RML 6–100 –0.0330 ± 0.00310 0.0105 ± 0.00420 0.9998 0.97 2.95
LSL 6–60 0.01634 ± 0.00973 0.0293 ± 0.00531 0.9997 1.10 3.32
thod was observed from the excipients, as indicated by good recovery (Table III). The
absence of interference from these excipients was attributed to the extraction with an or-
ganic solvent prior to the analysis.
Analysis of dosage forms
Commercially available pharmaceutical dosage forms of the investigated com-
pounds were subjected to the analysis by the proposed and reported spectrophotometric
methods for RML (12) and LSL (13), and the obtained results were then statistically com-
pared. The amounts of RML and LSL measured by the proposed procedure were compa-
rable with those obtained by the reported methods. In the t- and F-tests, no significant
differences were found between the calculated and theoretical values of both the pro-
posed and reported methods at 95 % confidence level. This indicated comparable accu-
racy and precision in the analysis by the proposed and reported methods.
CONCLUSIONS
The present study described the development and validation of a novel analytical
approach for reducing by 50-fold the consumption of organic solvents in the spectropho-
tometric analysis based on CT reactions. In this approach, the reaction was carried out in
96-microwell plates (200-mL reaction volume) instead of the conventional volumetric flasks.
The color signals were measured by a microwell-plate reader instead of a conventional
spectrophotometer. The analytical approach described herein has the following advan-
tages:
(i) Reduction in the consumption of organic solvents in the CT-based spectrophotome-
tric analysis and accordingly reduction in the exposure of analysts to the toxic ef-
fects of organic solvents.
(ii) Reduction by 50-fold in analysis costs, which can be reflected on the price of fin-
ished dosage forms, thus reducing the expenses for medications.
(iii) Provision of a high throughput analytical methodology that can facilitate the pro-
cessing of a large number of samples in a relatively short time. This property was
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Table V. Analysis of RML and LSL in their dosage forms by the proposed and reported methods
Dosage form
Amounts found (mg per tablet)a
t-testb F-testb
Proposed method Reported method (12, 13)
Tritace® tablets
(2.5 mg RML per tablet)
2.52 ± 0.04 2.53 ± 0.04 0.55 1.37
Zestril® tablets
(20 mg LSL per tablet)
20.10 ± 0.26 19.7 ± 0.34 1.95 1.73
a Mean ± SD (n = 6).
b The tabulated values of t- and F- at 95 % confidence limit (n = 6) are 2.78 and 6.39, resp.
attributed to the use of multi-channel pipettes for efficient dispensing of the solu-
tions, carrying out the analytical reaction in 96-well plates (as reaction vessels), and
measuring the color signals in the 96 wells at ~30 seconds by the plate reader.
(iv) Although the approach was developed and validated for the analysis ramipril and
lisinopril, it is also anticipated that the same methodology could be used for practi-
cally any analyte that can exhibit electron-donating capability.
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S A  E T A K
Novi analiti~ki pristup sa smanjenom potro{njom organskih otapala
u spektrofotometrijskoj analizi temeljenoj na prijenosu naboja:
Primjena u analizi nekih antihipertenziva
IBRAHIM A. DARWISH, ASHRAF M. MAHMOUD i ABDUL-RAHMAN A. AL-MAJED
U radu je opisan razvoj novog analiti~kog pristupa koji 50 puta smanjuje potro{nju
organskih otapala u spektrofotometrijskoj analizi na bazi prijenosa naboja (CT). Predlo-
`ena metoda koristi plo~e s 96 ja`ica za izvo|enje analize. CT reakcije izme|u elektron-
-donora i elektron-akceptora izvode se u ja`icama s 200-µL organskog otapala. Promjene
boje mjere se pomo}u posebnog mikro~ita~a za plo~e s ja`icama. Odre|eni su optimalni
uvjeti za dva antihipertenzivna lijeka, ramipril (RML) i lizinopril (LSL) koji su upotreb-
ljeni kao modelni spojevi za elektron-donorske analite, i 2,3-diklor-5,6-dicijano-1,4-ben-
zokinon (DDQ) kao -elektronski akceptor. U optimalnim uvjetima Beerov zakon je
vrijedio u koncentracijskom podru~ju 6–100 i 6–60 g mL1 za RML, odnosno LSL. Gra-
nice detekcije bile su 0,97 i 1,1 g mL1 za RML, odnosno LSL. Preciznost metode bila je
zadovoljavaju}a, a relativna standardna devijacija bila je manja od 1,1 %. Predlo`ena me-
toda uspje{no je primijenjena za analizu doziranih farmaceutskih pripravaka koji sadr`e
ispitivane lijekove, uz dobru to~nost i preciznost. Rezultati predlo`ene metode uspore-
divi su s rezultatima poznatih metoda. Postupak opisan u ovom radu vrlo je prakti~an:
analiti~ari su manje izlo`eni toksi~nim u~incima organskih otapala, tro{kovi analize
smanjeni su 50 puta, a tako|er ju odlikuje visoka propusnost. Iako je postupak validiran
za RML i LSL, ista metoda mo`e se upotrijebiti za elektron-doniraju}i analit koji ulazi u
CT reakciju.
Klju~ne rije~i: reakcija prijenosa naboja, organsko otapalo, spektrofotometrija, ramipril, lizinopril
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